TKPHF - Takeda Pharmaceutical Company Limited

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 51.62B
Enterprise value 78.09B
Trailing P/E 24.84
Forward P/E 11.47
PEG Ratio (5 yr expected) 0.61
Price/sales (ttm)1.73
Price/book (mrq)1.10
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 312.66%
S&P500 52-week change 30.07%
52-week high 334.47
52-week low 325.07
50-day moving average 332.99
200-day moving average 330.07

Share statistics

Avg vol (3-month) 352.67k
Avg vol (10-day) 33.07k
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 11.23%
% held by institutions 142.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.39
Forward annual dividend yield 44.32%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 3560.22%
5-year average dividend yield 44.22
Payout ratio 489.14%
Dividend date 327 Jun 2010
Ex-dividend date 427 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2023
Most-recent quarter (mrq)30 Mar 2023


Profit margin 7.87%
Operating margin (ttm)13.88%

Management effectiveness

Return on assets (ttm)2.58%
Return on equity (ttm)5.27%

Income statement

Revenue (ttm)4.03T
Revenue per share (ttm)2,595.34
Quarterly revenue growth (yoy)9.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)317.02B
Diluted EPS (ttm)1.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)533.53B
Total cash per share (mrq)343.21
Total debt (mrq)4.92T
Total debt/equity (mrq)77.37
Current ratio (mrq)0.97
Book value per share (mrq)4,087.49

Cash flow statement

Operating cash flow (ttm)977.16B
Levered free cash flow (ttm)468.63B